证券公司对LifeMD的误导性言论进行调查,引发潜在的集体诉讼诉讼。 Securities firms investigate LifeMD over misleading statements, sparking potential class action lawsuits.

证券诉讼公司正在调查LifeMD, Inc., 公司宣布在2025年第二季度增加客户收购成本,导致其股价下跌44%. Securities litigation firms are investigating LifeMD, Inc., following the company's announcement of increased customer acquisition costs in Q2 2025, which led to a 44% drop in its stock price. 调查以及随后提起的诉讼指称,人寿监测公司就其财务健康和业务业务作了误导性陈述。 The investigation and subsequent lawsuits allege that LifeMD made misleading statements about its financial health and business operations. 在2025年5月7日至8月5日期间购买人寿监测公司的证券的投资者可能有权参加集体诉讼并寻求赔偿。 Investors who purchased LifeMD's securities between May 7 and August 5, 2025, may be entitled to join the class action and seek compensation.